Mark Baillet
Impact in
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Peptidase Inhibition and Analysis
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 3
- Peptidase Inhibition and Analysis 3
- Colorectal Cancer Treatments and Studies 2
- Pancreatic and Hepatic Oncology Research 1
-
- Venous Thromboembolism Diagnosis and Management 1
- Co-authors
- Peter de Nully Brown (3 shared papers)Simon R. Bramhall (2 shared papers)John J. Nemunaitis (1 shared paper)J Schulz (1 shared paper)J.A.C. Buckels (1 shared paper)J W L Fielding (1 shared paper)M T Hallissey (1 shared paper)Peter G. McCulloch (1 shared paper)
- Journals
- British Journal of Cancer (3 papers)Journal of Allergy and Clinical Immunology (1 paper)Allergy (1 paper)Journal of Neuro-Oncology (1 paper)European Heart Journal (1 paper)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Mark Baillet
9 papers receiving 1.3k citations
Mark Baillet's Hit Papers
Peers
Comparison fields: 5 of 99
- Cancer Research 355
- Oncology 557
- Modeling and Simulation 75
- Infectious Diseases 206
- Immunology and Allergy 63
Countries citing papers authored by Mark Baillet
This map shows the geographic impact of Mark Baillet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Baillet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Baillet more than expected).
Fields of papers citing papers by Mark Baillet
This network shows the impact of papers produced by Mark Baillet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Baillet. The network helps show where Mark Baillet may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Baillet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 466 | |
| 2 | Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults Hit paper breakdown → | 2022 | 343 |
| 3 | 2002 | 217 | |
| 4 | 2014 | 112 | |
| 5 | 2006 | 104 | |
| 6 | 1999 | 57 | |
| 7 | 1996 | 10 | |
| 8 | 1984 | 6 | |
| 9 | 2014 | 1 |
About Mark Baillet
Mark Baillet is a scholar working on Oncology, Internal Medicine, Physiology, Pulmonary and Respiratory Medicine and Hematology, having authored 9 papers that have together received 1.3k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (3 papers), Asthma and respiratory diseases (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Venous Thromboembolism Diagnosis and Management (1 paper), COVID-19 Clinical Research Studies (1 paper), Respiratory and Cough-Related Research (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Cancer Research (355 citations), Oncology (557 citations), Modeling and Simulation (75 citations), Infectious Diseases (206 citations) and Immunology and Allergy (63 citations). Mark Baillet has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Peter de Nully Brown, Simon R. Bramhall, John J. Nemunaitis, J Schulz, J.A.C. Buckels, J W L Fielding, M T Hallissey, Peter G. McCulloch, J H Scholefield and Gillian M. Tierney. Their work appears in journals such as British Journal of Cancer, Journal of Allergy and Clinical Immunology, Allergy, Journal of Neuro-Oncology and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.